{
  "trial_id": "NCT02518191",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, menopausal status, stage of breast cancer, planned chemotherapy regimen, prior use of hormonal treatments, human chorionic gonadotropin status, presence of significant chronic disease, organ function status, history of metastatic lesions, history of bilateral ovariectomy, history of ovarian radiation, history of adjuvant endocrine therapy, presence of uterine or adnexal diseases, allergy status to GnRHa.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "menopausal status"
        ],
        [
          "Categorical",
          "stage of breast cancer"
        ],
        [
          "prior use of hormonal treatments",
          "prior use of hormonal treatments"
        ],
        [
          "human chorionic gonadotropin status",
          "human chorionic gonadotropin status"
        ],
        [
          "presence of significant chronic disease",
          "presence of significant chronic disease"
        ],
        [
          "organ function status",
          "organ function status"
        ],
        [
          "history of metastatic lesions",
          "history of metastatic lesions"
        ],
        [
          "history of bilateral ovariectomy",
          "history of bilateral ovariectomy"
        ],
        [
          "history of ovarian radiation",
          "history of ovarian radiation"
        ],
        [
          "history of adjuvant endocrine therapy",
          "history of adjuvant endocrine therapy"
        ],
        [
          "presence of uterine or adnexal diseases",
          "presence of uterine or adnexal diseases"
        ],
        [
          "allergy status to GnRHa",
          "allergy status to GnRHa"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "anti-M\u00fcllerian hormone (AMH)"
      ],
      "remaining_candidate_features": [
        "planned chemotherapy regimen"
      ]
    },
    "processed-gen-response": "Age, menopausal status, stage of breast cancer, planned chemotherapy regimen, prior use of hormonal treatments, human chorionic gonadotropin status, presence of significant chronic disease, organ function status, history of metastatic lesions, history of bilateral ovariectomy, history of ovarian radiation, history of adjuvant endocrine therapy, presence of uterine or adnexal diseases, allergy status to GnRHa."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Breast Cancer Stage, Hormone Receptor Status, HER2 Status, Type of Chemotherapy, Baseline Ovarian Function, Body Mass Index, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "anti-M\u00fcllerian hormone (AMH)"
      ],
      "remaining_candidate_features": [
        "Breast Cancer Stage",
        "Hormone Receptor Status",
        "HER2 Status",
        "Type of Chemotherapy",
        "Baseline Ovarian Function",
        "Body Mass Index"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Breast Cancer Stage, Hormone Receptor Status, HER2 Status, Type of Chemotherapy, Baseline Ovarian Function, Body Mass Index"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Menstrual Status, Region of Enrollment, Breast Cancer Stage, Chemotherapy Regimen, Baseline Follicle-Stimulating Hormone, Baseline Estradiol, Body Mass Index.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race/Ethnicity",
        "anti-M\u00fcllerian hormone (AMH)"
      ],
      "remaining_candidate_features": [
        "Menstrual Status",
        "Breast Cancer Stage",
        "Chemotherapy Regimen",
        "Baseline Follicle-Stimulating Hormone",
        "Baseline Estradiol",
        "Body Mass Index"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Menstrual Status, Region of Enrollment, Breast Cancer Stage, Chemotherapy Regimen, Baseline Follicle-Stimulating Hormone, Baseline Estradiol, Body Mass Index."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, body mass index, breast cancer stage, type of breast cancer, prior chemotherapy, prior hormonal therapy, menstrual cycle regularity, follicle-stimulating hormone level, estradiol level, anti-m\u00fcllerian hormone level, antral follicle count, presence of uterine and/or adnexal diseases.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ],
        [
          "anti-M\u00fcllerian hormone (AMH)",
          "anti-m\u00fcllerian hormone level"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Sex: Female",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index",
        "breast cancer stage",
        "type of breast cancer",
        "prior chemotherapy",
        "prior hormonal therapy",
        "menstrual cycle regularity",
        "follicle-stimulating hormone level",
        "estradiol level",
        "antral follicle count",
        "presence of uterine and/or adnexal diseases."
      ]
    },
    "processed-gen-response": "Age, race, ethnicity, body mass index, breast cancer stage, type of breast cancer, prior chemotherapy, prior hormonal therapy, menstrual cycle regularity, follicle-stimulating hormone level, estradiol level, anti-m\u00fcllerian hormone level, antral follicle count, presence of uterine and/or adnexal diseases."
  }
}